NEET-SS 2022

📚 01 General Pediatrics • 🎯 18 High-Yield MCQs • Nelson 22nd Edition Standard

Leukodystrophies & Metabolic Disorders

  • Krabbe Disease: ((GP22001)): Autosomal recessive lysosomal storage disorder caused by galactocerebrosidase (GALC) deficiency, leading to accumulation of psychosine and galactosylceramide which are toxic to oligodendrocytes/Schwann cells. Manifests within the first 6 months of life with extreme irritability, developmental regression, opisthotonos, spasticity, seizures, and optic atrophy.
  • Tyrosinemia Type I: ((GP22011)): Caused by deficiency of fumarylacetoacetate hydrolase (FAH ) resulting in toxic succinylacetone accumulation. Treated with dietary restriction and nitisinone (NTBC) (inhibitor of 4-hydroxyphenylpyruvate dioxygenase). Progressive liver failure requires liver transplantation.

Rheumatology & Immunology

  • Systemic Juvenile Idiopathic Arthritis (sJIA) & Cytokine Blockade: ((GP22002)): Refractory cases are treated with tocilizumab, a humanized monoclonal antibody against the interleukin-6 (IL-6) receptor. Decreases systemic inflammation and acute-phase reactants (CRP). - Infliximab / Etanercept: TNF-alpha inhibitors. - Rituximab: Anti-CD20 monoclonal antibody.

Dermatology & Infectious Diseases

  • Scabies: ((GP22003)): Caused by Sarcoptes scabiei var. hominis. Treatment of choice is 5% permethrin cream (not 1%) applied from the neck down (including scalp/face in infants) and left for 8–14 hours. Transmission via fomites is rare.
  • Rickettsial Infections: ((((GP22004)) · ((GP22008)))):
  • Treatment: : Doxycycline is the drug of choice for all rickettsial infections regardless of age, as the benefits strongly outweigh risks of dental staining.
  • Alternative: : Chloramphenicol is indicated if there is a documented allergy to doxycycline.

Neurocutaneous Syndromes & Neuromuscular Disorders

  • Tuberous Sclerosis Complex (TSC): ((GP22004)): Features hypomelanotic macules (ash-leaf spots best seen under Wood's lamp), facial angiofibromas, shagreen patches, and epileptic spasms. First-line treatment for infantile spasms associated with TSC is vigabatrin (superior to ACTH/steroids).
  • Spinal Muscular Atrophy Type 3 (SMA-3): ((GP22014)): Mildest form (Kugelberg–Welander disease) with onset after 18 months. Features proximal muscle weakness, positive Gower sign, but normal serum creatine phosphokinase (CPK) levels (unlike muscular dystrophies).

Neonatology & Critical Care

  • Refeeding Syndrome: ((GP22005)): Occurs in severe malnutrition when carbohydrates restart insulin secretion, shifting phosphate, potassium, and magnesium intracellularly. The hallmark is hypophosphatemia, leading to ATP depletion, tachycardia, tachypnea, and hepatomegaly.
  • Drowning-Induced Cerebral Edema: ((GP22006)): Irreversible neuronal anoxic injury occurs within 3–5 minutes, but cerebral edema peaks and manifests clinically approximately 12 hours post-arrest.
  • Subgaleal Hemorrhage: ((GP22015)): Scalp bleeding into the potential space between the periosteum and aponeurosis. A 1 cm expansion of this space can accommodate ~40 ml of blood (over 40% of neonatal blood volume), rapidly inducing hypovolemic shock. Triad: tachycardia, falling hematocrit, and increasing occipitofrontal circumference.

Genetics & Dysmorphology

  • Congenital Cataracts & Trisomies: ((GP22007)): Lenticular opacities are classically associated with Trisomy 13 (Patau), Trisomy 18 (Edwards), and Trisomy 21 (Down), but not with Trisomy 5.
  • Anticipation: ((GP22016)): Phenomenon where a genetic disorder presents at an earlier age and with increased severity in successive generations, classically seen in trinucleotide repeat expansion disorders (e.g., Myotonic dystrophy, Fragile X, Huntington disease).
  • Genetic Mutations: ((GP22017)): The most common type of disease-causing mutations are missense or nonsense variants (~56%).
  • Penetrance vs. Expressivity: ((GP22018)): Non-penetrance describes an individual carrying a pathogenic variant who shows no phenotypic manifestation. Variable expressivity describes differing severity/symptoms among individuals with the exact same genotype.